Published in Am J Cardiol on October 01, 1991
Arrhythmias in patients with acute coronary syndrome in the first 24 hours of hospitalization. Heart Lung (2013) 0.81
Ventricular arrhythmias in congestive heart failure: clinical significance and management. Tex Heart Inst J (1999) 0.80
Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol (2016) 0.75
Grouped beating in eisenmenger: successful localization and ablation of an accelerated idioventricular rhythm from within the purkinje system. Indian Pacing Electrophysiol J (2013) 0.75
Catheter ablation of long-lasting accelerated idioventricular rhythm in a patient with mild left ventricular dysfunction. Case Rep Cardiol (2012) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Smoking and myocardial infarction. Lancet (1975) 3.42
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation (1992) 2.43
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94
A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80
Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76
Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med (1973) 1.76
Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J (1998) 1.73
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol (2001) 1.68
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Stressful life events, social support, and mortality in men born in 1933. BMJ (1993) 1.66
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol (1991) 1.63
Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med (1992) 1.62
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene (2012) 1.62
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke (1990) 1.59
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Sinus arrest during REM sleep in young adults. N Engl J Med (1984) 1.53
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ (1988) 1.53
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. Eur Heart J (2001) 1.49
Association between ease of suppression of ventricular arrhythmia and survival. Circulation (1995) 1.48
Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J (1989) 1.47
Activation of cardiac tissue by extracellular electrical shocks: formation of 'secondary sources' at intercellular clefts in monolayers of cultured myocytes. Circ Res (1998) 1.46
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. Eur Heart J (1998) 1.45
Modeling mortality fluctuations in Los Angeles as functions of pollution and weather effects. Environ Res (1988) 1.44
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Improved long-term prognosis after myocardial infarction 1984-1991. Eur Heart J (1998) 1.42
Fatalities from myocardial infarction in Nordic countries and Lithuania. The MONICA Investigators. Eur Heart J (1997) 1.42
Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Nephrol Dial Transplant (1998) 1.39
Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarction. Acta Med Scand (1977) 1.38
Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med (2000) 1.35
Low systolic blood pressure and self perceived wellbeing in middle aged men. BMJ (1993) 1.32
A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol (1984) 1.32
Stroke trends in the WHO MONICA project. Stroke (1997) 1.30
Antihypertensive effect and side-effects of bendroflumethiazide and propranolol. Acta Med Scand (1976) 1.29
Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf) (1994) 1.29
Effects of electric arc welding on ventilatory lung function. Arch Environ Health (1979) 1.29
Identification of cases of myocardial infarction: hospital discharge data and mortality data compared to myocardial infarction community registers. Int J Epidemiol (1991) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Alcoholic intemperance, coronary heart disease and mortality in middle-aged Swedish men. Acta Med Scand (1987) 1.26
A controlled trial of physical training after myocardial infarction. Effects on risk factors, nonfatal reinfarction, and death. Prev Med (1975) 1.26
Pharmacodynamics and side effects of flecainide acetate. Clin Pharmacol Ther (1986) 1.23
Guidelines for pacemaker follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. Can J Cardiol (2000) 1.21
Education of adult patients at an "asthma school": effects on quality of life, knowledge and need for nursing. Eur Respir J (1990) 1.21
Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis (1993) 1.20
Factors related to blood pressure in a general population sample of Swedish men. Acta Med Scand (1975) 1.19
The biosynthesis of phospholipids and their precursors in rat liver involving de novo methylation, and base-exchange pathways, in vivo. Biochim Biophys Acta (1973) 1.16
Marital status and mortality in middle-aged Swedish men. Am J Epidemiol (1989) 1.16
Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med (2004) 1.15
Gender and regional differences in perceived job stress across Europe. Eur J Public Health (2005) 1.15
Male risk factors for hip fracture-a 30-year follow-up study in 7,495 men. Osteoporos Int (2009) 1.13
A postmyocardial infarction clinic in Göteborg, Sweden. A follow-up of MI patients in a specialized out-patient clinic. Acta Med Scand (1975) 1.13
Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J (1966) 1.11
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis (2009) 1.10
Perceived stress and incidence of Type 2 diabetes: a 35-year follow-up study of middle-aged Swedish men. Diabet Med (2013) 1.10
Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency. Clin Endocrinol (Oxf) (1998) 1.10
Non-participants in a general population study of men, with special reference to social and alcoholic problems. Acta Med Scand (1987) 1.09
Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) (1993) 1.09
A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry (2012) 1.09
Body temperature in general population samples. The study of men born in 1913 and 1923. Acta Med Scand (1985) 1.09
Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med (2004) 1.09
Relationship between juvenile obesity, dietary energy and fat intake and physical activity. Int J Obes Relat Metab Disord (2002) 1.09
Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol (1997) 1.09